ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 135 filers reported holding ARCUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 4.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,619,212 | +269.7% | 1,037,282 | +318.3% | 0.22% | +263.3% |
| Q2 2023 | $5,036,880 | -79.7% | 248,000 | -79.4% | 0.06% | -81.9% |
| Q4 2022 | $24,839,782 | +201.1% | 1,201,150 | +359.5% | 0.33% | +147.8% |
| Q1 2022 | $8,250,000 | -88.1% | 261,419 | -84.7% | 0.13% | -86.5% |
| Q4 2021 | $69,059,000 | +16.6% | 1,706,425 | +0.4% | 0.99% | +2.3% |
| Q3 2021 | $59,248,000 | +29.7% | 1,699,113 | +2.1% | 0.97% | +13.5% |
| Q2 2021 | $45,682,000 | +31.4% | 1,663,568 | +34.4% | 0.85% | +10.5% |
| Q1 2021 | $34,755,000 | +2442.4% | 1,237,730 | +1156.4% | 0.77% | +686.7% |
| Q1 2020 | $1,367,000 | – | 98,516 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |